{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:55:06Z","timestamp":1793130906081,"version":"4.5.0"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.3951","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T15:01:44Z","timestamp":1588604504000},"page":"e203951","source":"Crossref","is-referenced-by-count":46,"title":["Comparative Effectiveness of Antibiotic Treatment Duration in Children With Pyelonephritis"],"prefix":"10.1001","volume":"3","author":[{"given":"Miriam T.","family":"Fox","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Amoah","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice J.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie A.","family":"Herzke","sequence":"additional","affiliation":[{"name":"Department of Medicine and Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Gerber","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranita D.","family":"Tamma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"issue":"10","key":"zoi200189r1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1542\/pir.26-10-364","article-title":"Pyelonephritis.","volume":"26","author":"Raszka","year":"2005","journal-title":"Pediatr Rev"},{"issue":"6","key":"zoi200189r2","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1542\/peds.2010-0685","article-title":"Risk of renal scarring in children with a first urinary tract infection: a systematic review.","volume":"126","author":"Shaikh","year":"2010","journal-title":"Pediatrics"},{"issue":"8","key":"zoi200189r3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00467-015-3168-5","article-title":"Acute pyelonephritis in children.","volume":"31","author":"Morello","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"zoi200189r4","article-title":"Antibiotics for acute pyelonephritis in children.","author":"Strohmeier","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"zoi200189r5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1542\/peds.2011-1330","article-title":"Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months.","volume":"128","author":"Roberts","year":"2011","journal-title":"Pediatrics"},{"issue":"6","key":"zoi200189r6","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3026","article-title":"Reaffirmation of AAP clinical practice guideline: The diagnosis and management of the initial urinary tract infection in febrile infants and young children 2-24 months of age.","volume":"138","author":"Subcommittee on Urinary Tract Infection","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"zoi200189r7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10096-017-2951-6","article-title":"Is 5 days of oral fluoroquinolone enough for acute uncomplicated pyelonephritis? The DTP randomized trial.","volume":"36","author":"Dinh","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"zoi200189r8","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/jac\/dkt177","article-title":"Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection\u20137 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials.","volume":"68","author":"Eliakim-Raz","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"zoi200189r9","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1185\/030079907X233340","article-title":"A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and\/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis.","volume":"23","author":"Klausner","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"zoi200189r10","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"9","key":"zoi200189r11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients.","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"9596","key":"zoi200189r13","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"zoi200189r14","article-title":"Comparing propensity score methods versus traditional regression analysis for the evaluation of observational data: a case study evaluating the treatment of gram-negative bloodstream infections.","author":"Amoah","journal-title":"Clin Infect Dis"},{"issue":"3","key":"zoi200189r15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.7326\/M19-1509","article-title":"Duration of antibiotic therapy: Shorter is better.","volume":"171","author":"Spellberg","year":"2019","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi200189r16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/phar.2018.38.issue-6","article-title":"Shortened courses of antibiotics for bacterial infections: A systematic review of randomized controlled trials.","volume":"38","author":"Hanretty","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"12","key":"zoi200189r17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1542\/pir.28-12-474","article-title":"Cystitis.","volume":"28","author":"Azzarone","year":"2007","journal-title":"Pediatr Rev"},{"issue":"3","key":"zoi200189r18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.pcl.2006.02.011","article-title":"Pediatric urinary tract infections.","volume":"53","author":"Chang","year":"2006","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"zoi200189r19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.18203\/2349-3291.ijcp20175583","article-title":"Risk factors for urinary tract infection in pediatric patients.","volume":"5","author":"Kavitha","year":"2017","journal-title":"Int J Contemp Pediatr"},{"issue":"8","key":"zoi200189r20","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jama.293.8.949","article-title":"Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.","volume":"293","author":"Hooton","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"zoi200189r21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/003655401750173922","article-title":"Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime.","volume":"33","author":"Cronberg","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"7","key":"zoi200189r22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.amjmed.2017.01.025","article-title":"A seven-day course of TMP-SMX may be as effective as a seven-day course of ciprofloxacin for the treatment of pyelonephritis.","volume":"130","author":"Fox","year":"2017","journal-title":"Am J Med"},{"key":"zoi200189r12","unstructured":"Chesapeake Regional Information System for our Patients (CRISP). Accessed March 24, 2019. https:\/\/www.crisphealth.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2765372\/fox_2020_oi_200189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T15:02:40Z","timestamp":1588604560000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2765372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3951","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]}}}